Lyra Therapeutics Inc Quick Ratio (LYRA) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Lyra Therapeutics Inc   (NASDAQ: LYRA)

Lyra Therapeutics Inc 's Quick Ratio

LYRA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2025, Quick Ratio fell to 1.24 a new company low.

Within Medical Equipment & Supplies industry 106 other companies have achieved higher Quick Ratio than Lyra Therapeutics Inc in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from 897 to 1854.

Explain Quick Ratio?
How much Cash & cash equivalents LYRA´s has?
What are LYRA´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LYRA Quick Ratio (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2		 (Mar 31 2025)
Q1		 (Dec 31 2024)
Q4
Y / Y Current Liabilities Change 1.2 % -36.61 % -42.09 % -35.15 % -35.55 %
Y / Y Cash & cash equivalent Change -60.83 % -57.28 % -55.87 % -63.57 % -60.51 %
Quick Ratio MRQ 1.24 2.33 2.67 2.77 3.21
LYRA's Total Ranking # 1854 # 897 # 800 # 687 # 489
Seq. Current Liabilities Change 34.83 % -15.08 % -2.68 % -9.19 % -15.53 %
Seq. Cash & cash equivalent Change -27.94 % -25.95 % -6.15 % -21.79 % -21.4 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 107
Healthcare Sector # 643
Overall Market # 1854


Quick Ratio Statistics
High Average Low
21.97 7.23 1.24
(Jun 30 2020)   (Dec 31 2025)




Financial Statements
Lyra Therapeutics Inc 's Current Liabilities $ 13 Millions Visit LYRA's Balance sheet
Lyra Therapeutics Inc 's Cash & cash equivalent $ 16 Millions Visit LYRA's Balance sheet
Source of LYRA's Sales Visit LYRA's Sales by Geography


Cumulative Lyra Therapeutics Inc 's Quick Ratio

LYRA's Quick Ratio for the trailling 12 Months

LYRA Quick Ratio

 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months		 (Mar 31 2025)
12 Months		 (Dec 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth -30.45 % -37.43 % -32.2 % -1.1 % 19.67 %
Y / Y Cash & cash equivalent TTM Growth -59.7 % -59.82 % -57.29 % -53.14 % -38.93 %
Quick Ratio TTM 2.22 2.77 3.06 3.28 3.82
Total Ranking TTM # 3953 # 2894 # 2957 # 2382 # 3100
Seq. Current Liabilities TTM Growth 0.34 % -10.9 % -13.91 % -9.63 % -9.74 %
Seq. Cash & cash equivalent TTM Growth -19.88 % -19.24 % -19.7 % -22.44 % -20.12 %

Quick ratio ranking by company, industry and sector >> Back to LYRA Financial Strength Comparisons >> Go to Compare LYRA Quick Ratio to its Competitors

On the trailing twelve months basis Due to growth in Current Liabilities in the Q4 2025 to $12.78 millions, cumulative Quick Ratio decreased to 2.22 below the Lyra Therapeutics Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 205 other companies have achieved higher Quick Ratio than Lyra Therapeutics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from 2894 to 3953.

Explain Quick Ratio?
How much Cash & cash equivalents LYRA´s has?
What are LYRA´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 206
Healthcare Sector # 976
Within the Market # 3953


trailing twelve months Quick Ratio Statistics
High Average Low
17.45 6.09 2.39
(Mar 31 2021)   (Dec 31 2025)




Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Medical Equipment & Supplies Industry Quick RatioDec 31 2025 MRQ Cash & cash equivalentDec 31 2025 MRQ Current Liabilities
Co diagnostics Inc   3.36 $ 11.885  Millions$ 3.540  Millions
Mobia Medical Inc   3.29 $ 33.587  Millions$ 10.206  Millions
Strata Critical Medical Inc   3.21 $ 61.495  Millions$ 19.142  Millions
Inspire Medical Systems inc   3.21 $ 308.268  Millions$ 96.055  Millions
Seastar Medical Holding Corp  3.20 $ 11.980  Millions$ 3.742  Millions
Brainsway Ltd   3.01 $ 67.700  Millions$ 22.495  Millions
Femasys Inc   2.99 $ 9.266  Millions$ 3.096  Millions
Hyperfine Inc   2.99 $ 35.085  Millions$ 11.732  Millions
Penumbra Inc  2.97 $ 544.816  Millions$ 183.133  Millions
Intuitive Surgical Inc   2.96 $ 5,934.900  Millions$ 2,006.200  Millions
Aethlon Medical Inc   2.90 $ 5.501  Millions$ 1.899  Millions
Neuroone Medical Technologies Corp  2.85 $ 6.570  Millions$ 2.303  Millions
Tela Bio Inc   2.83 $ 50.845  Millions$ 17.975  Millions
Glaukos Corp  2.75 $ 278.760  Millions$ 101.275  Millions
Staar Surgical Co  2.74 $ 187.536  Millions$ 68.504  Millions
Apyx Medical Corp  2.71 $ 31.740  Millions$ 11.700  Millions
Adagio Medical Holdings inc   2.65 $ 20.586  Millions$ 7.763  Millions
Mimedx Group Inc   2.58 $ 166.121  Millions$ 64.266  Millions
Axe Compute Inc  2.53 $ 10.791  Millions$ 4.267  Millions
Longduoduo Co Ltd  2.47 $ 0.968  Millions$ 0.393  Millions
Vivani Medical Inc   2.46 $ 16.232  Millions$ 6.602  Millions
Dariohealth Corp   2.36 $ 22.032  Millions$ 9.323  Millions
Capsovision Inc   2.28 $ 10.112  Millions$ 4.427  Millions
Sharps Technology Inc   2.21 $ 10.383  Millions$ 4.695  Millions
Tactile Systems Technology Inc   2.21 $ 83.446  Millions$ 37.762  Millions
Myomo Inc   2.20 $ 18.394  Millions$ 8.345  Millions
Inogen Inc   2.18 $ 119.577  Millions$ 54.869  Millions
Atricure Inc   2.05 $ 167.428  Millions$ 81.520  Millions
Edwards Lifesciences Corporation  1.99 $ 5,526.800  Millions$ 2,773.600  Millions
Axogen inc   1.96 $ 41.528  Millions$ 21.184  Millions

Date modified: 2026-07-07T12:01:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.